The tricyclic trimipramine in the treatment of subjective tinnitus.
We examined 26 consecutive patients with subjective tinnitus. All subjects were treated with the tricyclic antidepressant trimipramine in a double-blind study, each subject acting as his own control. All subjects were evaluated with pure tone audiometry, site of lesion testing, and auditory brain stem evoked response. The tinnitus assessment consisted of frequency and intensity matching, the determination of masking levels, and a subjective evaluation of severity. Plasma levels of trimipramine were monitored at regular intervals, and the Zung and Millon inventories were administered at the beginning and end of each study period. Nineteen subjects completed the study. Within the trimipramine group, one reported complete disappearance of his tinnitus, eight reported improvement, three no change, and seven that tinnitus was worse. Within the placebo group, eight reported improvement, seven no change, and four that tinnitus was worse. The natural history of tinnitus is such that what has been observed may reflect the evolution of the disease itself, rather than the effect of treatment. We feel that while tricyclics may not have been shown to be effective, the placebo effect played a significant role in the results obtained.
Mihail
R C
RC
Department of Otolaryngology-Head and Neck Surgery, Walter Reed Army Medical Center, Washington, DC.
Crowley
J M
JM
Walden
B E
BE
Fishburne
J
J
Reinwall
J E
JE
Zajtchuk
J T
JT
D000328:Adult; D000368:Aged; D001301:Audiometry, Pure-Tone; D003984:Dibenzazepines / Q000627:therapeutic use*; D004311:Double-Blind Method; D005072:Evoked Potentials, Auditory / Q000187:drug effects; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance; D011446:Prospective Studies; D011581:Psychological Tests; D014012:Tinnitus / Q000188:drug therapy* / Q000209:etiology; D014299:Trimipramine / Q000097:blood / Q000627:therapeutic use*
D003984:Dibenzazepines; D014299:Trimipramine